ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

Lapatinib plus paclitaxel as first-line therapy for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: inappropriate conclusions from a company-sponsored study?

Eitan Amir et al.PubMed ↗Publisher ↗

No numbers read from the abstract.